Formulation
| Each film-coated tablet contains: | |
|---|---|
| Calcium-4-methyl-2-oxo-valerate (α-ketoanalogue to leucine, calcium salt) | 101 mg |
| Calcium-2-oxo-3-phenylpropionate (α-ketoanalogue to phenylalanine, calcium salt) | 68 mg |
| Calcium-3-methyl-2-oxo-valerate (α-ketoanalogue to isoleucine, calcium salt) | 67 mg |
| Calcium-DL-2-hydroxy-4-(methylthio)butyrate (α-hydroxyanalogue to methionine, calcium salt) | 59 mg |
| L-Lysine Acetate | 105 mg |
| L-Threonine | 53 mg |
| L-Histidine | 38 mg |
| L-Tyrosine | 30 mg |
| L-Tryptophan | 23 mg |
Ketoanalogues +
Essential Amino Acids
Alfaren®
Prescription Drug
Indication
Prevention and treatment of damages due to faulty or deficient protein metabolism in chronic kidney disease in connection with a limited dietary protein intake of 40g/day or less (adults). Usually this applies to patients whose glomerular filtration rate (GFR) is less than 25mL/min.
Dosage and Administration:
For more information on safety, precaution and other information about this product, please see the Product Information Leaflet
